What role will the CRA play in future clinical trials?

Key developments in technology will continue to impact the role CRAs undertake in clinical trials. Where previously, a CRA would have undertaken a considerable amount of admin responsibilities, this will not be the case as we move into the future. Tools such as Artificial Intelligence (AI) will be leveraged to undertake much of this work, such as document reviews and data collation. In turn, this will leave CRAs to take on a more strategic position, freeing up their time to focus on analysing the data and making decisions.

Although technology will play a greater role in clinical trials in the coming years, professional CRAs will continue to be a crucial part of clinical trials in the future. The increased use of technology in this field will likely increase the importance of the 'human touch'.    

A CRA's presence on site will be especially crucial since they continue to offer the human side of trials and provide training tailored to their needs. In addition, CRAs will also assist site staff in understanding protocols and compliance requirements. Clinical trials would likely cease to function efficiently and reliably without this level of service.    

One big challenge for CRAs, especially when it comes to applying a ‘human touch’, is the continued growth of virtual clinical trials. This shift happened in large part due to the Covid-19 pandemic limiting the potential of contact between those managing trials and those participating. Today, this trend continues due to the flexibility it allows within clinical trials, unlocking opportunities without concern for distance.

As this trend continues, CRAs will need to adapt their style of working to fit into their new virtual work environments. Consequently, we will likely need to make use of a variety of new digital and physical tools to be able to control communication more effectively and record data more accurately.    

Careers in clinical trials have always been exciting, fast-paced and occasionally unpredictable. With uncertain markets across the globe, this is now truer than ever before. Again, this uncertainty is due largely to the huge challenges presented to the medical industry during the Covid-19 pandemic. But it is also influenced by other economic and political factors across the board.    

As we move into the future, CRAs will need to remain agile. Skill in assessing the changing landscape and being able to develop strategic approaches to overcoming new challenges will be more desirable than ever in the clinical research space. This is especially true when it comes to new rules and regulations, which are changing at an accelerating rate.      

The future of clinical trials will be exciting and fast-paced. CRAs will continue to play a major part in these trials, making it the perfect option for those that want a challenging and rewarding career. We have several great opportunities for clinical research associates at ICON. Or, you can find more information about our CRA learning opportunities.